Trained at Stanford Medical Center and a Georgetown University School of Medicine graduate, Dr
No systematic adverse-event data from controlled trials Regulatory note / FDA warned against compounding pharmacies marketing BPC-157 in 2023 and 2024 What Is BPC-157 and Why Is It Used Off-Label for GI Healing
For menopause, the key is the formulary and prior authorization process
A novel target for next-generation obesity medications is nicotinamide N-methyltransferase (NNMT) 7,8,9,10,11 , an enzyme central to cellular metabolism and energy homeostasis 12
Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24.11 (NEP 24.11) and renal clearance, resulting in a half-life of approximately 2 minutes
Reconstituted Dry powder is inherently more stable since degradation reactions require a solvent medium